229 related articles for article (PubMed ID: 24968069)
1. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis.
Ng W; Kennar R; Uetrecht J
Chem Res Toxicol; 2014 Jul; 27(7):1104-8. PubMed ID: 24968069
[TBL] [Abstract][Full Text] [Related]
2. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
Iverson S; Zahid N; Uetrecht JP
Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
[TBL] [Abstract][Full Text] [Related]
3. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
4. Effect of aminoglutethimide on neutrophils in rats: implications for idiosyncratic drug-induced blood dyscrasias.
Ng W; Uetrecht J
Chem Res Toxicol; 2013 Aug; 26(8):1272-81. PubMed ID: 23889370
[TBL] [Abstract][Full Text] [Related]
5. Effect of clozapine on neutrophil kinetics in rabbits.
Iverson S; Kautiainen A; Ip J; Uetrecht JP
Chem Res Toxicol; 2010 Jul; 23(7):1184-91. PubMed ID: 20553052
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis.
Uetrecht JP
Drug Saf; 1992; 7 Suppl 1():51-6. PubMed ID: 1503678
[TBL] [Abstract][Full Text] [Related]
7. Clozapine promotes the proliferation of granulocyte progenitors in the bone marrow leading to increased granulopoiesis and neutrophilia in rats.
Lobach AR; Uetrecht J
Chem Res Toxicol; 2014 Jul; 27(7):1109-19. PubMed ID: 24968143
[TBL] [Abstract][Full Text] [Related]
8. Testing the hypothesis that vitamin C deficiency is a risk factor for clozapine-induced agranulocytosis using guinea pigs and ODS rats.
Ip J; Wilson JX; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):869-73. PubMed ID: 18380445
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes.
Gardner I; Zahid N; MacCrimmon D; Uetrecht JP
Mol Pharmacol; 1998 Jun; 53(6):991-8. PubMed ID: 9614200
[TBL] [Abstract][Full Text] [Related]
10. Structural features associated with reactive metabolite formation in clozapine analogues.
Uetrecht J; Zahid N; Tehim A; Fu JM; Rakhit S
Chem Biol Interact; 1997 May; 104(2-3):117-29. PubMed ID: 9212779
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo.
Gardner I; Leeder JS; Chin T; Zahid N; Uetrecht JP
Mol Pharmacol; 1998 Jun; 53(6):999-1008. PubMed ID: 9614201
[TBL] [Abstract][Full Text] [Related]
12. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS
Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
[No Abstract] [Full Text] [Related]
13. Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
Li X; Cameron MD
Chem Res Toxicol; 2012 May; 25(5):1004-11. PubMed ID: 22506851
[TBL] [Abstract][Full Text] [Related]
14. Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis.
Pereira A; Dean B
Biochem Pharmacol; 2006 Sep; 72(6):783-93. PubMed ID: 16844094
[TBL] [Abstract][Full Text] [Related]
15. Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: implications for fluperlapine-induced agranulocytosis.
Lai WG; Gardner I; Zahid N; Uetrecht JP
Drug Metab Dispos; 2000 Mar; 28(3):255-63. PubMed ID: 10681368
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Extracellular Vesicles in the Proinflammatory Response to Clozapine: Implications for Clozapine-Induced Agranulocytosis.
Sernoskie SC; Bonneil É; Thibault P; Jee A; Uetrecht J
J Pharmacol Exp Ther; 2024 Feb; 388(3):827-845. PubMed ID: 38262745
[TBL] [Abstract][Full Text] [Related]
17. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
[TBL] [Abstract][Full Text] [Related]
18. [A case study; ethnicity and clozapine, a risky combination?].
Laan WJ; Ramlal D
Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
Sayin A; Cosar B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
[TBL] [Abstract][Full Text] [Related]
20. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
